SEARCH

Current Edition

active

Pro-Electrophiles A Previously Overlooked Class of Protein-reactive Extractables?

Extractable and leachable studies on primary packaging systems are well-established in the pharmaceutical industry. For extraction studies, guidelines and best practice guides mandate a worst-case …

Continue Reading →
COVID-19

Drug price hikes moderate as rebates rise, report finds

Dive Brief: List prices of branded drugs in the U.S. rose by an average of nearly 5% last year, according to a report released Thursday …

Continue Reading →
biotechnology

CHARNWOOD MOLECULAR UNVEILS CUTTING EDGE LABORATORIES

Charnwood Molecular, a leading UK-based pre-clinical discovery CRO serving the global pharmaceutical and biotechnology market, has officially opened its new facilities at Charnwood Campus, Loughborough. …

Continue Reading →
CCS

Contamination Control Strategy

Regulatory bodies expect that pharmaceutical companies have a Contamination Control Strategy (CCS) in place that outlines the control of contamination of utilities, manufacturing systems and …

Continue Reading →
AstraZeneca

AstraZeneca builds case for long-acting COVID-19 drug, but is it too late?

In some ways, AstraZeneca’s COVID-19 response has been as good as any in the biopharmaceutical industry. The British drugmaker licensed and developed an effective COVID-19 …

Continue Reading →
AstraZeneca

AstraZeneca strikes deal with university spinoff to turn RNA into drugs

The success of the mRNA vaccines developed by Moderna and BioNTech has drawn significant attention, and new funding, to the technology that allows drug developers …

Continue Reading →
drugs and technologies

Sanofi to buy Kadmon for $1.9B, extending deal streak

Sanofi has agreed to buy Kadmon Holdings for $1.9 billion, the latest in a string of acquisitions the French pharmaceutical giant has used to add …

Continue Reading →
Bayer

How Bayer lured a biotech away from an IPO and into a buyout

In what has become a common move by large pharmaceutical companies attempting to revitalize their drug research, German healthcare conglomerate Bayer has acquired a small …

Continue Reading →
drugmakers

Pfizer’s fast progress shines spotlight on an emerging vaccine race

Drugmakers have laboured for decades to successfully develop a vaccine to protect infants and older people against infections of a common pathogen called respiratory syncytial …

Continue Reading →
biopharma group
A-D

Biopharma Group

The Biopharma Group comprises of Biopharma Process Systems (BPS), Biopharma Technologies Ltd (BTL), Biopharma Technology LLC (USA) and Biopharma Technologies France (BTF). Equipment Sales & Service Division: BPS …

Continue Reading →